Research output

  1. Letter: tricky reactions to switch back from subcutaneous to intravenous vedolizumab in inflammatory bowel disease patients—authors' reply

    Research output: Contribution to journal › Comment/Letter to the editor › Academic

  2. Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations

    Research output: Contribution to journal › Article › Academic › peer-review

  3. Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases

    Research output: Contribution to journal › Review article › Academic › peer-review

View all (10) »

ID: 7672607